- Pfizer revealed that it is already manufacturing “hundreds of thousands of doses” of its COVID-19 vaccine.
- The drugmaker expects to distribute 100 million doses this year, of which 40 million are destined for the UK.
- The news puts Pfizer at the top of the race to launch a vaccine against COVID-19.
Pharmaceutical Pfizer revealed that it is already manufacturing “hundreds of thousands of doses” of its COVID-19 vaccine at its Puurs, Belgium plant.
The drug giant announced that it expects to distribute 100 million doses this year, of which 40 million are destined for the United Kingdom, a figure that will be dwarfed by the 1.3 million vaccines that the company intends to manufacture in 2021, reported Daily Mail.
Pfizer is stockpiling these doses ready for implementation if clinical trials are successful and regulatory bodies consider it a safe and effective vaccine.
In this case, the pharmacist ensures that each patient who receives the vaccine will need two doses to achieve an immunization.
In an interview with The Mail this Sunday, Ben Osborn, head of Pfizer UK, said: “It was great to see the first vial coming off the manufacturing line. It just brought me a tremendous smile to see that all this work really turns out to be a product. “
Pfizer, which is working with Germany’s BioNTech, is conducting a trial with 44,000 people, and said last week it plans to apply for emergency approval of the vaccine in the United States in November.
This news puts Pfizer at the top of the race to launch a vaccine against COVID-19.
Meanwhile, the UK’s National Health Service (NHS) reported on Sunday that it is preparing to introduce a coronavirus vaccine shortly after Christmas.
UK Deputy Chief Medical Officer Jonathan Van-Tam told MPs last week that all three stages of the vaccine created at the University of Oxford, which is being produced by Astra Zeneca, could be deployed in December, reports Sunday. Times.